Only 16.8% of the patients with anemia included in this study were treated with EPO, and only 17.4–22.8% of the patients with anemia were treated with iron, folic acid, vitamin B12, and other hematopoietic ingredients. The gene discussed is EPO; the disease is anemia (phenotype).